Avances en Diabetología最新文献_第5页

¿Qué podemos esperar del control de la variabilidad glucémica? 我们能从控制血糖变化中期待什么?

Avances en Diabetología Pub Date : 2014-05-01 DOI: 10.1016/j.avdiab.2014.03.001

Manuel Delgado Gómez

引用次数: 2

Utilidad de la creación de una consulta monográfica de nuevas tecnologías en el tratamiento de pacientes con diabetes mellitus tipo 1 mediante infusión subcutánea continua de insulina 为持续皮下胰岛素输注治疗1型糖尿病患者的新技术创建专题咨询的效用

Avances en Diabetología Pub Date : 2014-05-01 DOI: 10.1016/j.avdiab.2014.04.001

Jesús Moreno-Fernández, Angela M. Seco Segura, Pedro Rozas Moreno, Manuel Delgado del Rey, Abel González González, Miguel Aguirre Sánchez-Covisa

引用次数: 2

Luces y sombras en la epidemiología de la diabetes de tipo 1 1型糖尿病流行病学的光明与阴影

Avances en Diabetología Pub Date : 2014-03-01 DOI: 10.1016/j.avdiab.2013.12.001

Luis Forga, María José Goñi

引用次数: 5

Estado nutricional y presión arterial en niños de la provincia del Chaco, Argentina 阿根廷查科省儿童的营养状况和血压

Avances en Diabetología Pub Date : 2014-03-01 DOI: 10.1016/j.avdiab.2014.02.003

María Eugenia V. Bianchi , Marcelo Slimel , Ricardo K. Tannuri , Mayra F. Valdez , Ana María Cusumano , Gustavo A. Velasco

{"title":"Estado nutricional y presión arterial en niños de la provincia del Chaco, Argentina","authors":"María Eugenia V. Bianchi , Marcelo Slimel , Ricardo K. Tannuri , Mayra F. Valdez , Ana María Cusumano , Gustavo A. Velasco","doi":"10.1016/j.avdiab.2014.02.003","DOIUrl":"10.1016/j.avdiab.2014.02.003","url":null,"abstract":"<div><p>Chaco Province, Argentina, has a population of 1,055,259 inhabitants, and has one of the largest pediatric and indigenous populations in the country.</p><p>The aim of this study was to determine the blood pressure (BP) and nutritional status (NS) in the pediatric population in Chaco Province and to describe the differences between the Caucasian population (CP), and a group of Toba aborigines (AT) less than 10 years old.</p><p>This study was conducted on a non-random sample of 678 children of 1-17 years who did not attend medical appointments. The tables developed by WHO 2007 were used to determine NS. BP was taken by adapting the technique described in the Fourth BP Report.</p><p>Depending on age and ethnicity, the participating children were divided into four groups. In Group <span>I</span>, 90 (13.3%) AT under 10 years, group <span>II</span>, 52 (7.7%) of CP of the same age range, group <span>III</span>, 190 (28%) CP 11-13 years, and in group <span>IV</span>, 346 (51%) CP 4-17 years. There was a risk of overweight and overweight, in between 24% and 46% of children, and underweight in 2.7% (95% CI; 1.6 to 4.2).</p><p>Blood pressure above or equal to the 95 percentile was detected in 42% of Group <span>I</span>, 30% of Group <span>II</span>, 20% of group <span>III</span>, and 16% of group <span>IV</span> (<em>p</em>  <!-->.05).</p><p>The prevalence of overweight is higher than that that found in other studies from Canada and Buenos Aires, Argentina, and lower than in the United States. The AT had a higher frequency of normal weight and shorter stature.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.02.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79999101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura 与2型糖尿病成本相关的主要因素:文献综述

Avances en Diabetología Pub Date : 2014-03-01 DOI: 10.1016/j.avdiab.2014.02.001

Silvia Paz , Diego González Segura , Anna Raya Torres , Luis Lizan

引用次数: 6

I Workshop ibérico sobre la asociación entre diabetes y enfermedades periodontales. Documento de consenso 关于糖尿病和牙周病之间关系的伊比利亚讲习班。共识文件

Avances en Diabetología Pub Date : 2014-03-01 DOI: 10.1016/j.avdiab.2014.02.002

David Herrera González , Albert Goday Arno , Ricardo Faria Almeida , Alfonso López Alba , Héctor Juan Rodríguez Casanova , José Luis Herrera Pombo

{"title":"I Workshop ibérico sobre la asociación entre diabetes y enfermedades periodontales. Documento de consenso","authors":"David Herrera González , Albert Goday Arno , Ricardo Faria Almeida , Alfonso López Alba , Héctor Juan Rodríguez Casanova , José Luis Herrera Pombo","doi":"10.1016/j.avdiab.2014.02.002","DOIUrl":"10.1016/j.avdiab.2014.02.002","url":null,"abstract":"<div><p>This consensus report has been prepared by a group of experts from the Spanish Foundations of Diabetes and of Periodontology. The reviewed evidence shows relevant data that strongly support the importance of diabetes and periodontal diseases, as well as their bi-directional relationship:</p><p>- Diabetes has a high prevalence in Spain and Portugal, with a high prevalence of un-diagnosed diabetes, and with continuously increasing rates. In addition, the frequency and severity of their complications is also very important.</p><p>- Periodontal diseases have high prevalence, close to 90% in adult populations. The destructive capacity of periodontitis leads to tooth loss, which is associated with a profound impact on the patients. Periodontitis have also been related to an increased risk of cardiovascular diseases, adverse pregnancy outcomes, and pulmonary infections, as well as other conditions.</p><p>- Numerous studies have concluded that diabetes is a significant risk factor for periodontitis, especially in subjects with poor glycemic control.</p><p>- Periodontal diseases have been shown to have a deleterious effect on glycemic control, both in diabetic patients and healthy subjects, and it has been demonstrated that diabetes complications are more frequent in diabetic patients with periodontitis.</p><p>- Periodontal treatment has been associated with improvements in glycemic control, with a mean reduction in glycosylated haemoglobin of 0.4%.</p><p>Based on the above evidence, different challenges are proposed for health professionals involved in diabetic and periodontitis patient care.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2014.02.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83736922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Características clínicas y tratamiento hipoglucemiante en pacientes con diabetes tipo 2 e inadecuado control glucémico de un área de salud de Castilla-La Mancha, España 西班牙卡斯蒂利亚-拉曼查地区2型糖尿病和血糖控制不足患者的临床特征和低血糖治疗

Avances en Diabetología Pub Date : 2014-03-01 DOI: 10.1016/j.avdiab.2014.01.001

Pedro José Pinés Corrales, Pilar Ibáñez Navarro, Ángela Vicente Albiñana

引用次数: 0

Intervención farmacéutica en la prescripción de metformina en pacientes con diabetes mellitus tipo 2 e insuficiencia renal 二甲双胍在2型糖尿病和肾衰竭患者处方中的药物干预

Avances en Diabetología Pub Date : 2014-01-01 DOI: 10.1016/j.avdiab.2013.11.002

Manuel Vélez-Díaz-Pallarés, Isabel Cuesta-López, Ana Álvarez-Díaz, Covadonga Pérez-Menéndez-Conde, Eva Delgado-Silveria, Teresa Bermejo-Vicedo

{"title":"Intervención farmacéutica en la prescripción de metformina en pacientes con diabetes mellitus tipo 2 e insuficiencia renal","authors":"Manuel Vélez-Díaz-Pallarés, Isabel Cuesta-López, Ana Álvarez-Díaz, Covadonga Pérez-Menéndez-Conde, Eva Delgado-Silveria, Teresa Bermejo-Vicedo","doi":"10.1016/j.avdiab.2013.11.002","DOIUrl":"10.1016/j.avdiab.2013.11.002","url":null,"abstract":"<div><h3>Objective</h3><p>To implement a pharmaceutical care program for hospitalized patients with moderate to severe renal insufficiency treated with metformin and to analyze the impact of pharmaceutical intervention in its prescribing.</p></div><div><h3>Material and method</h3><p>Prospective intervention study developed in a general hospital of 1,080 beds over a 2.5 month period. An algorithm was designed in order to use metformin depending on creatinine clearance. In patients suffering from severe renal insufficiency the pharmaceutical intervention was to recommend the discontinuation of the drug, while for moderate insufficiency other factors were considered. The degree of acceptance of the pharmaceutical intervention was calculated, and whether there was any episode of metformin-induced lactic acidosis.</p></div><div><h3>Results</h3><p>Renal insufficiency (16.1-59.8ml/min creatinine clearance) was observed in 11.5% of the patients taking metformin. Almost two-thirds (65.3%) of them had other comorbidities that also contraindicated the use of metformin. Acceptance of pharmaceutical interventions was 65.7%, reaching 80% if the patient suffered from severe renal impairment.</p></div><div><h3>Conclusions</h3><p>The implementation of a pharmaceutical care program for diabetic patients with moderate to severe renal insufficiency using metformin resulted in the safe use of the drug. The degree of acceptance of the pharmaceutical interventions was good and there were no episodes of metformin-induced lactic acidosis.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2013.11.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91191436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Reclasificación de una diabetes mellitus tipo 1 en diabetes neonatal permanente y transferencia efectiva de insulina a sulfonilurea 1型糖尿病在新生儿永久性糖尿病中的重新分类与胰岛素向磺酰脲的有效转移

Avances en Diabetología Pub Date : 2014-01-01 DOI: 10.1016/j.avdiab.2013.10.002

Guillermo Serra-Soler , Bárbara Manga , Magnolia Navarro-Falcón , Mercè Codina-Marcet

引用次数: 1

Aspectos clínicamente relevantes para pacientes diabéticos en tratamiento con insulina: prevención de hipoglucemias y flexibilidad en la administración 胰岛素治疗糖尿病患者的临床相关方面:低血糖的预防和给药的灵活性

Avances en Diabetología Pub Date : 2014-01-01 DOI: 10.1016/j.avdiab.2013.10.001

Francisco Javier Ampudia-Blasco

引用次数: 1